...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why have we not heard more about CURATE-AI?

Hummmmm,,its all very odd,, at the time the press release was made it noted that the stage 4 prostate cancer was cured on this particular individual. This was unheard of at the time and it was pointed out that it was thru this AI platform the dosing matched the care for overcoming the disease. No follow up of importance yet the results are unprecedented! Was the release fake news?,,are we being fed bovine excrement????,,the math around events somehow just dont match up with the present circumstances imo. It is all very confusing to the lay person!!!

Share
New Message
Please login to post a reply